Pirino B, Spodnick M, Gargiulo A, Curtis G, Barson J, Karkhanis A. Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis. Neuropharmacology. 2020;181:108341 pubmed publisher

Li X, Sun Y, Jin Q, Song D, Diao Y. Kappa opioid receptor agonists improve postoperative cognitive dysfunction in rats via the JAK2/STAT3 signaling pathway. Int J Mol Med. 2019;44:1866-1876 pubmed publisher

Dziedowiec E, Nayak S, Gruver K, Jennings T, Tallarida C, Rawls S. Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians. Neuroscience. 2018;386:214-222 pubmed publisher

Liu J, Sharma K, Zangrandi L, Chen C, Humphrey S, Chiu Y, et al. In vivo brain GPCR signaling elucidated by phosphoproteomics. Science. 2018;360: pubmed publisher

Polter A, Barcomb K, Chen R, Dingess P, Graziane N, Brown T, et al. Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress. elife. 2017;6: pubmed publisher

Zhou L, Lovell K, Frankowski K, Slauson S, Phillips A, Streicher J, et al. Development of functionally selective, small molecule agonists at kappa opioid receptors. J Biol Chem. 2013;288:36703-16 pubmed publisher

Kharmate G, Rajput P, Lin Y, Kumar U. Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells. Cancer Cell Int. 2013;13:93 pubmed publisher

Grachev P, Li X, Lin Y, Hu M, Elsamani L, Paterson S, et al. GPR54-dependent stimulation of luteinizing hormone secretion by neurokinin B in prepubertal rats. PLoS ONE. 2012;7:e44344 pubmed publisher

Marchant N, Furlong T, McNally G. Medial dorsal hypothalamus mediates the inhibition of reward seeking after extinction. J Neurosci. 2010;30:14102-15 pubmed publisher